搜索临床试验以:Non-Small Cell Lung Carcinoma (NSCLC)
总计115939个结果
-
Intergroupe Francophone de Cancerologie Thoracique主动,不招人
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Frontier Science Foundation, Hellas完全的
-
Beta Pharma Shanghai完全的
-
AstraZenecaQuintiles, Inc.完全的局部晚期或转移性非小细胞肺癌(IIIB-IV 期)美国
-
National Taiwan University Hospital未知
-
Alliance Foundation Trials, LLC.AstraZeneca主动,不招人
-
Geneplus-Beijing Co. Ltd.Shanghai Chest Hospital完全的肺肿瘤 | 肺腺癌 | 肺癌,非小细胞 | 鳞状细胞肺癌中国
-
Tongji University招聘中
-
Astellas Pharma Global Development, Inc.撤销具有 EGFR 激活突变的 NSCLC 受试者
-
National Cancer Institute (NCI)终止
-
Regeneron PharmaceuticalsSanofi终止
-
Alexander Chi尚未招聘
-
Gruppo Oncologico Italiano di Ricerca Clinica招聘中
-
Novartis Pharmaceuticals主动,不招人
-
Gruppo Oncologico Italiano di Ricerca ClinicaBioikos Ambiente Srl; Istituto Toscano Tumori; Temas srl; Mipharm S.p.A.; Bristol Myers Squibb Srl...主动,不招人
-
Betta Pharmaceuticals Co., Ltd.未知
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.招聘中
-
Fondazione Policlinico Universitario Agostino Gemelli...招聘中
-
Suzhou Puhe Pharmaceutical Technology Co., LTD尚未招聘
-
Mirati Therapeutics Inc.完全的
-
HiberCell, Inc.完全的
-
Hellenic Oncology Research Group完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.完全的
-
Achieve Life Sciences完全的
-
Royal Marsden NHS Foundation TrustBristol-Myers Squibb主动,不招人